Skip to main content

Table 1 Acute exacerbations in the INPULSIS® trials

From: Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials

 

Adjudication result

 
 

Confirmed/suspected acute exacerbation

Not an acute exacerbation

Total

Adverse event category

Serious adverse event

31

18

49*

Non-serious adverse event

5

9

14*

Total

36

27

63

  1. *One patient had an acute exacerbation reported as a non-serious adverse event followed by an acute exacerbation reported as a serious adverse event. In subsequent analyses, this patient was classified according to his worse event